SCHEMBL7908528

SCHEMBL7908528

Cc1cccc(C(N)=O)c1S

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.46
MYC P01106 1/20 0.46
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 2/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SIRT3 Q9NTG7 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
METAP2 P50579 1/20 0.42
GAA P10253 1/20 0.41
BCAT2 O15382 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30786246 1.00 PARP1 (0.46) PARP1MYCALDH1A1HPGDKDM4E
SCHEMBL1545846 0.83 BRPF1 (0.46) MYCALDH1A1HPGDKDM4EHSD17B10
SCHEMBL2960119 0.83 ALDH1A1 (0.61) MYCALDH1A1HPGDKDM4EHSD17B10
SCHEMBL16555030 0.81 KDM4E (0.43) PARP1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL29136545 0.80 MAPT (0.46) PARP1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL30933674 0.80 ESR1 (0.49) PARP1MYCALDH1A1HPGDKDM4E
SCHEMBL160022 0.80 ESR1 (0.49) PARP1MYCALDH1A1HPGDKDM4E
SCHEMBL6099 0.79 ALDH1A1 (0.56) MYCALDH1A1HPGDKDM4EHSD17B10
SCHEMBL1558192 0.79 ALDH1A1 (0.56) MYCALDH1A1HPGDKDM4EHSD17B10
Cresotamide SCHEMBL1806785 0.78 ALDH1A1 (0.67) PARP1MYCALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200268694-A1 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES FIRST WAVE BIO, INC. 2020-08-27 US disclosed
CN-107734969-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 美国陶氏益农公司 2018-02-23 CN disclosed
US-9328067-B2 Sulfur derivatives as chemokine receptor modulators ALLERGAN, INC. (US) 2016-05-03 US disclosed
CN-102124000-B Pyridine compounds ASTRAZENECA AB 2014-09-17 CN disclosed
CN-101679191-B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them SANOFI AVENTIS SPA 2014-03-12 CN disclosed
US-20130252984-A1 SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-09-26 US disclosed
US-6197803-B1 VIRICIDES; PREVENTION REPRODUCTION AMERICAN HOME PRODUCTS CORPORATION 2001-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200268694-A1 METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES FH, CS, ECHS1 PARP1 4576/4885MYC 3565/4885ALDH1A1 2168/4885
US-20130252984-A1 SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS CX3CR1, CXCR2, CCR2 PARP1 4316/4885MYC 4626/4885ALDH1A1 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.